Caraco Pharmaceutical Laboratories Ltd announces a voluntary recall across the US of all lots of Digoxin tablets due to size variability.

Caraco Pharmaceutical Laboratories Ltd (Caraco) announced that all tablets of Caraco brand Digoxin, USP, 0.125 mg, and Digoxin, USP, 0.25 mg, distributed prior to 31 Mar 2009, which are not expired and are within the expiration date of Sep 2011, are being voluntarily recalled to the consumer level. The tablets are being recalled because they may differ in size and therefore could have more or less of the active ingredient, digoxin. The recalled tablets were manufactured by Caraco Pharmaceutical Laboratories Ltd. This recall is being conducted with the knowledge of the Food and Drug Administration. Digoxin is a drug product used to treat heart failure and abnormal heart rhythms. …